All about health

Omeros Corporation today reported that clinical trial site activation for enrollment is underway for the company's Phase 3 program evaluating zaltenibart in paroxysmal nocturnal hemoglobinuria (PNH). Zaltenibart (OMS906) is Omeros' investigational...

Frederick "Derick" Cooper, CEO of QOL Medical, a pharmaceutical company specializing in treatments for rare gastrointestinal diseases, has donated $75,000 to Beacon Rescue, a 501(c)(3) nonprofit Search and Rescue agency. Known for its team of highly...

The Board of Directors of Bioretec Ltd has on 21st of March 2025 resolved, on the basis of the authorization granted by the company's Annual General Meeting on 21st of March 2025, to establish a new option program as an incentive scheme for Alan...

The Annual General Meeting of Bioretec Ltd was held on 21 March 2025 in Tampere, Finland. The Annual General Meeting approved the financial statements for the financial year 1 January-31 December 2024 and resolved to discharge the members of the...

VantAI today unveiled Neo-1, the world's most advanced atomistic foundation model and the first to unify de novo molecular generation with multimodal structure prediction, at NVIDIA GTC 2025. Neo-1 is designed to make the systematic re-wiring of...

To follow up on the completion of its clinical proof-of-concept study, SynerFusetm and its partner, Velentium Medical, today announced plans to scale the patented SynerFusetm e-TLIFtm procedure implant device. "With the completion of our...

A research study co-authored by Florida Cancer Specialists & Research Institute (FCS) physicians and senior leaders will be featured in an encore presentation at the MOASC 2025 Annual Oncology Summit & Research Symposium. FCS Director of Real-World...

PharmAla Biotech Holdings Inc. ("PharmAla" or the "Company") , a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its LaNeotm MDMA), is pleased to announce that it has...

The Government of Canada is committed to building stronger, healthier communities across the country. The transformative power of sport plays an important role in achieving this goal. Today, Parliamentary Secretary Adam van Koeverden announced an...

Shanghai Moyom Biotechnology's high-profile brand, Aphranel® MagiCCrystal CaHA Filler, has officially obtained Class III Medical Device Certificate from the China National Medical Products Administration (NMPA) (Registration Certificate Number.:...

Dr. Scholl's®, the iconic brand known for delivering comfort and support, is stepping up to celebrate the previously unsung heroes of the sports world?sports moms. Launching a new campaign titled "The [Un]Official Sponsor of Sports Moms," Dr....

Wellpointe Inc., an affordable, boutique-style residential assisted living provider that operates at the intersection of healthcare and real estate, is pleased to announce the addition of Anna Kobrzak, CPA, JD, as Corporate Controller. With over 20...

American Public University System (APUS) has earned initial accreditation for its Master of Science Healthcare Administration (MSHA) program from the Commission on Accreditation of Healthcare Management Education (CAHME). The accreditation recognizes...

OsteoStrong, a global leader in skeletal strength conditioning, is expanding with a new location in Gothenburg, Sweden, offering residents a cutting-edge, drug-free solution to enhance bone density, strength and overall skeletal health in just...

Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, published positive results from the VERIFI clinical validation of its next-generation test for pancreatic cancer on March 19, 2025. As a follow up, Immunovia will host a...

A revolutionary moment in aesthetics is here as Sunshine Botanicals, a leader in holistic skin therapy, joins forces with the Ashley DeRamus Foundation to empower individuals with Down syndrome. This groundbreaking collaboration marks a historic...

This National Fragrance Day, AXE Canada is shaking up modern dating by putting scent front and centre. With dating app fatigue at an all-time high, AXE is offering a fresh alternative to finding a date ? scented wild postings featuring four real,...

VolitionRx Limited ('Volition'), a multi-national epigenetics company, today announces the results of a study which shows that an automated Nu.Q® Cancer immunoassay test in development detected a range of 21 different cancers. This could potentially...

Accelerate Diagnostics, Inc. today reports financial results for the fourth quarter and year ended December 31, 2024. 2024 Fourth...

IceCure Medical Ltd.  ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced that it will issue a press...

The "FDA Inspection" training has been added to ResearchAndMarkets.com's offering. This seminar provides the fundamentals and the ground rules on how to prepare for and survive an FDA inspection no matter if you are a Class I, II, III device or a...

Accuryn Medical, a company dedicated to addressing acute kidney injury through real-time renal monitoring and assessment based on global clinical practice guidelines, today announced that Todd Dunn, Accuryn's Chief Transformation Officer, will...

Pulmatrix, Inc. ("Pulmatrix" or the "Company") , a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs...

Syneron Bio, a cutting-edge oral macrocyclic peptide drug biotech company, announced today a strategic collaboration with the global biopharmaceutical leader AstraZeneca to develop potential first-in-class macrocyclic peptides for the treatment of...

Vireo Growth Inc. ("Vireo" or the "Company") , today announced several updates regarding its previously-announced acquisition transactions (collectively, the "Merger Transactions"), which are now expected to close during the second quarter following...

TURKU, FI / ACCESS Newswire / March 21, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) Results of the Annual General Meeting, Change of Directors, Decision of the Board meeting after the AGMTURKU, FINLAND - The annual general meeting...

Gundry MD®, a leader in health and wellness supplements, is proud to announce that their product, Gundry MD Total Restore®, has now surpassed 7 million units sold. This remarkable achievement highlights the growing trust and satisfaction of customers...

OS Therapies ("OS Therapies" or "the Company"), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today announced that Paul Romness, CEO, and Gerald Commissiong, CBO will be accepting meetings with...

Anteris Technologies Global Corp. (Anteris® or the Company) a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, today announced one-year results...

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent accomplishments and...